US 11,666,378 B2
Systems and methods for therapeutic nasal neuromodulation
David Townley, County Clare (IE); and Brian Shields, County Galway (IE)
Assigned to Neurent Medical Limited, Oranmore (IE)
Filed by Neurent Medical Limited, Oranmore (IE)
Filed on Dec. 3, 2019, as Appl. No. 16/701,843.
Claims priority of provisional application 62/896,845, filed on Sep. 6, 2019.
Claims priority of provisional application 62/832,927, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,914, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,918, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,923, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,920, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,925, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,928, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,917, filed on Apr. 12, 2019.
Claims priority of provisional application 62/778,233, filed on Dec. 11, 2018.
Prior Publication US 2020/0179681 A1, Jun. 11, 2020
Int. Cl. A61B 18/14 (2006.01); A61B 34/10 (2016.01); A61B 34/20 (2016.01); A61N 1/05 (2006.01); G06T 7/00 (2017.01); A61N 1/40 (2006.01); A61B 90/00 (2016.01); A61B 90/92 (2016.01); A61B 90/94 (2016.01); A61B 18/02 (2006.01); A61B 18/12 (2006.01); A61B 18/20 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61B 18/18 (2006.01)
CPC A61B 18/1485 (2013.01) [A61B 18/14 (2013.01); A61B 34/10 (2016.02); A61B 34/20 (2016.02); A61N 1/0546 (2013.01); A61N 1/403 (2013.01); G06T 7/0012 (2013.01); A61B 18/02 (2013.01); A61B 18/1206 (2013.01); A61B 18/20 (2013.01); A61B 90/92 (2016.02); A61B 90/94 (2016.02); A61B 2017/00199 (2013.01); A61B 2017/00292 (2013.01); A61B 2017/00424 (2013.01); A61B 2017/00867 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/00166 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00303 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00654 (2013.01); A61B 2018/00815 (2013.01); A61B 2018/00821 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00922 (2013.01); A61B 2018/00946 (2013.01); A61B 2018/126 (2013.01); A61B 2018/1253 (2013.01); A61B 2018/144 (2013.01); A61B 2018/1407 (2013.01); A61B 2018/1467 (2013.01); A61B 2018/1475 (2013.01); A61B 2018/1823 (2013.01); A61B 2034/102 (2016.02); A61B 2090/376 (2016.02); A61B 2090/378 (2016.02); A61B 2090/3735 (2016.02); A61B 2090/3762 (2016.02); A61B 2218/007 (2013.01)] 10 Claims
OG exemplary drawing
 
1. A device for treating a condition within a nasal cavity of a patient, the device comprising:
a shaft;
a multi-segment end effector operably associated with the shaft, the multi-segment end effector comprising a first segment and a separate and distinct second segment spaced apart from the first segment along a longitudinal axis along which a distal-most portion of the shaft lies, wherein each of the first and second segments is transformable between a retracted configuration and an expanded deployed configuration and comprises an associated architecture in the expanded deployed configuration;
wherein the first segment comprises:
a first set of a plurality of flexible support elements that extend in a first outward direction relative to the longitudinal axis and are positioned within a first half of the first segment and cooperatively form an inwardly extending first concave shape when the first segment is in the expanded deployed configuration; and
a second set of a plurality of flexible support elements that extend in a second outward direction relative to the longitudinal axis and substantially opposite the first outward direction and are positioned within a second half of the first segment and cooperatively form an inwardly extending second concave shape opposing the first concave shape when the first segment is in the expanded deployed configuration, the first and second sets of plurality of flexible support elements define the architecture of the first segment when in the expanded deployed configuration; and
a handle operably associated with the shaft, wherein at least the distal-most portion of the shaft comprises one or more markings that provide a user with a spatial orientation of one or more portions of at least the first segment of the multi-segment end effector while the first segment of the multi-segment end effector is in a nasal cavity and in the expanded deployed configuration.